Table 2.
Peptide frequency and group comparisons
| Freq. (%) ∗ | M/C | S/C | D/C | |
|---|---|---|---|---|
| APOC2 | ||||
| GIFTDQVLSVLKGEE | 60.00 | ↑ | ↑ | ↑ |
| ATP7A | ||||
| VESTSNSPSSS | 56.67 | ↑ | ↑ | ↑ |
| DACH1 | ||||
| IKERVPDSPSPAPSLEE | 58.33 | ↑ | ↑ | ↑ |
| KERVPDSPSPAPSLEE | 33.33 | ↑ | ↑ | ↑ |
| VPDSPSPAPSLEE | 66.67 | ↑ | ↑ | ↔ |
| DACH2 | ||||
| ESPSPAPSLEE | 45.00 | ↔ | ↔ | ↔ |
| KERIPESPSPAPSLEE | 46.67 | ↑ | ↑ | ↔ |
| FAT2 | ||||
| DGSDVSK | 30.00 | ↔ | ↔ | ↑ |
| FIBA | ||||
| ADSGEGDFLAEGGGVR | 61.67 | ↑ | ↑ | ↔ |
| DSGEGDFLAEGGGVR | 65.00 | ↑ | ↔ | ↑ |
| GEGDFLAEGGGVR | 63.33 | ↑ | ↑ | ↑ |
| SGEGDFLAEGGGVR | 46.67 | ↑ | ↑ | ↑ |
| IRGQ | ||||
| LLALPPASPSAARTKA | 31.67 | ↑ | ↔ | ↑ |
| KNG1 | ||||
| RPPGFSPFR (bradykinin) | 45.00 | ↔ | ↑ | ↔ |
| ZN541 | ||||
| SPSEESPPGPGG | 50.00 | ↔ | ↔ | ↔ |
M, moderate infection; S, severe infection; D, infection that led to death during hospitalization; C, non-SARS-CoV-2-infected individuals. Freq. (%)∗, percentage of mass spectrometry runs whose peptide sequence was identified. Symbols indicate: ⟷, no change in peptide ratio, p > 0.05; ↑ or ↓, respectively, peptide ratio either increased or decreased, p < 0.05. See also Table S5 for results segmented by sex.